151.4100 -5.09 (-3.25%)
NSE Jan 23, 2026 15:31 PM
Volume: 2.7M
 

Edelweiss
CDMO business to drive growth
Piramal Pharma Ltd. has an average target of 262.67 from 3 brokers.
More from Piramal Pharma Ltd.
Recommended